Exenatide Acetate D5

Exenatide Acetate D5 is a synthetic peptide drug that is used to treat Type 2 Diabetes Mellitus. This drug is a derivative of the naturally occurring hormone known as Glucagon-like Peptide-1 (GLP-1) and has been designed to mimic its actions. Exenatide Acetate D5 works by stimulating the production of insulin in the pancreas and reducing the production of glucose in the liver. This results in lower blood glucose levels and improved glycemic control. Exenatide Acetate D5 is administered by subcutaneous injection and is typically used as a second-line treatment for Type 2 Diabetes Mellitus. It is often prescribed in combination with other diabetes medications, such as Metformin or Sulfonylureas, to achieve optimal glycemic control. The drug is available in a pre-filled pen device, which makes it easy for patients to self-administer. The chemical structure of Exenatide Acetate D5 is similar to that of GLP-1, with the addition of a five-carbon isotopic label (D5). The isotopic label is used to track the absorption, distribution, and metabolism of the drug in the body. Exenatide Acetate D5 has a molecular weight of 3994.7 g/mol and a chemical formula of C184H282N50O60S. The half-life of the drug is approximately 2.4 hours and it is primarily eliminated through renal clearance. Overall, Exenatide Acetate D5 is an effective and widely used drug for the treatment of Type 2 Diabetes Mellitus. Its unique chemical structure and mechanism of action make it a valuable tool in the management of this chronic disease.